These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6097532)

  • 21. Isolated bovine spinal motoneurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy.
    Yoshino H; Miyatani N; Saito M; Ariga T; Lugaresi A; Latov N; Kushi Y; Kasama T; Yu RK
    J Neurochem; 1992 Nov; 59(5):1684-91. PubMed ID: 1383424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of antiganglioside antibodies against experimental Trypanosoma brucei infection in mice.
    Uemura A; Watarai S; Ohnishi Y; Kodama H
    J Parasitol; 2005 Feb; 91(1):73-8. PubMed ID: 15856875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to GM1 ganglioside inhibit morphine analgesia.
    Karpiak SE
    Pharmacol Biochem Behav; 1982 Apr; 16(4):611-3. PubMed ID: 6280205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of monoclonal antibodies specific for ganglioside GM1: detection of ganglioside GM1 in small cell lung carcinoma cell lines and tissues.
    Watarai S; Kiura K; Shigeto R; Shibayama T; Kimura I; Yasuda T
    J Biochem; 1994 Nov; 116(5):948-54. PubMed ID: 7896755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro.
    Paparounas K; O'Hanlon GM; O'Leary CP; Rowan EG; Willison HJ
    Brain; 1999 May; 122 ( Pt 5)():807-16. PubMed ID: 10355667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
    Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
    J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to GM1 ganglioside inhibit a learned avoidance response.
    Karpiak SE; Graf L; Rapport MM
    Brain Res; 1978 Aug; 151(3):637-40. PubMed ID: 667639
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE.
    Endo T; Scott DD; Stewart SS; Kundu SK; Marcus DM
    J Immunol; 1984 Apr; 132(4):1793-7. PubMed ID: 6699401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy.
    Baba H; Daune GC; Ilyas AA; Pestronk A; Cornblath DR; Chaudhry V; Griffin JW; Quarles RH
    J Neuroimmunol; 1989 Dec; 25(2-3):143-50. PubMed ID: 2584393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunological model of epilepsy: seizures induced by antibodies to GM1 ganglioside.
    Karpiak SE; Mahadik SP; Graf L; Rapport MM
    Epilepsia; 1981 Apr; 22(2):189-96. PubMed ID: 7472306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactivity of a human monoclonal anti-GM1 and anti-GD1b IgM antibody with human neurons in cultures.
    Jauberteau MO; Brindel I; Baumann N; Preud'homme JL
    J Neuroimmunol; 1993 Oct; 48(1):53-7. PubMed ID: 8227308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-GM1 ganglioside IgM-antibodies present in human plasma: affinity and biological activity changes in a patient with neuropathy.
    Mitzutamari RK; Kremer LJ; Basile EA; Nores GA
    J Neurosci Res; 1998 Jan; 51(2):237-42. PubMed ID: 9469577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody dependent, complement mediated liver uptake of liposomes containing GM1.
    Liu D; Song YK; Liu F
    Pharm Res; 1995 Nov; 12(11):1775-80. PubMed ID: 8592685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of phospholipids on antiganglioside antibody reactivity in GBS.
    Hirakawa M; Morita D; Tsuji S; Kusunoki S
    J Neuroimmunol; 2005 Feb; 159(1-2):129-32. PubMed ID: 15652411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
    Mauri L; Casellato R; Ciampa MG; Uekusa Y; Kato K; Kaida K; Motoyama M; Kusunoki S; Sonnino S
    Glycobiology; 2012 Mar; 22(3):352-60. PubMed ID: 21921061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane expression of Thy-1,2 and GM1 ganglioside on differentiating T lymphocytes.
    Milewicz C; Miller HC; Esselman WJ
    J Immunol; 1976 Nov; 117(5 Pt.2):1774-80. PubMed ID: 1086862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls.
    Bansal AS; Abdul-Karim B; Malik RA; Goulding P; Pumphrey RS; Boulton AJ; Holt PL; Wilson PB
    J Clin Pathol; 1994 Apr; 47(4):300-2. PubMed ID: 8027366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of gangliosides in the interaction of a growth inhibitor with mouse LM cells.
    Bascom CC; Sharifi BG; Melkerson LJ; Rintoul DA; Johnson TC
    J Cell Physiol; 1985 Dec; 125(3):427-35. PubMed ID: 4066767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ELISA-type titertray assay of IgM anti-GM1 autoantibodies.
    Bech E; Jakobsen J; Orntoft TF
    Clin Chem; 1994 Jul; 40(7 Pt 1):1331-4. PubMed ID: 8013109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome.
    Neisser A; Schwerer B; Bernheimer H; Moran AP
    J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.